Recombinant Human RGS17 Protein，His

RGS17 (Regulator of G protein Signaling 17) is a member of the RGS protein family, which plays a crucial role in modulating G protein-coupled receptor (GPCR) signaling pathways. These pathways are essential for various physiological processes, including neurotransmission, hormone release, and cellular responses to external stimuli. RGS proteins act as GTPase-activating proteins (GAPs), accelerating the hydrolysis of GTP on Gα subunits and thus terminating signaling. Recent studies have indicated that RGS17 is not only involved in standard GPCR signaling but also has implications in cancer biology, particularly in certain types of tumors where its expression levels can influence cancer cell proliferation and survival. Understanding the structure and function of recombinant RGS17 proteins could provide critical insights into its specific regulatory mechanisms and interactions with GPCRs, potentially revealing novel therapeutic targets. The production of RGS17 as a recombinant protein allows researchers to investigate its biochemical properties and functional roles in signaling pathways, paving the way for advances in drug discovery and therapeutic interventions for diseases linked to dysregulated G protein signaling. Given the increasing recognition of the importance of RGS proteins in health and disease, RGS17 offers an intriguing area of research that may contribute to our understanding of GPCR-related diseases and the development of targeted therapies.